Skip to main content
. 2016 Jan 25;103(4):374–381. doi: 10.1002/bjs.10081

Figure 2.

BJS-10081-FIG-0002-c

CONSORT diagram for the trial. Reasons for postrandomization exclusion included: recurrent varicose veins and veins larger than 15 mm. Reasons for withdrawal from follow‐up included: patient decided not to proceed with treatment (and also declined follow‐up), declined follow‐up after treatment or did not wish to complete questionnaires. UGFS, ultrasound‐guided foam sclerotherapy; EVLA, endovenous laser ablation